Sector

Materials

51 companies under coverage across 13 industries.

Industries

Browse by industry

Aluminum 1 Commodity Chemicals 1 Construction Materials 5 Copper 1 Diversified Chemicals 3 Fertilizers & Agricultural Chemicals 4 Gold 4 Industrial Gases 2 Metal, Glass & Plastic Containers 4 Paper & Plastic Packaging Products & Materials 8 Silver 1 Specialty Chemicals 12 Steel 5

Coverage

Materials companies

Equity Research

Olin Corporation (OLN)

BUY. 12-month probability-weighted target $24 (+60% vs spot). Gross Margin explains 49% of Monte Carlo outcome variance.

OLNEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +63.1%

Equity Research

Scotts Miracle-Gro Company (SMG)

BUY. 12-month probability-weighted target $70 (+40% vs spot). Gross Margin explains 49% of Monte Carlo outcome variance.

SMGEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +33.7%

Equity Research

Silgan Holdings Inc (SLGN)

BUY. 12-month probability-weighted target $44 (+24% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

SLGNEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +27.3%

Equity Research

Sonoco Products Company (SON)

BUY. 12-month probability-weighted target $57 (+19% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

SONEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +24.6%

Equity Research

Albemarle Corp (ALB)

BUY. 12-month probability-weighted target $139 (+37% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

ALBEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +23.6%

Equity Research

CRH PLC ADR (CRH)

BUY. 12-month probability-weighted target $111 (+36% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

CRHEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +9.9%

Equity Research

Eagle Materials Inc (EXP)

BUY. 12-month probability-weighted target $199 (+21% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

EXPEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +5.5%

Equity Research

Westlake Chemical Corporation (WLK)

BUY. 12-month probability-weighted target $76 (+21% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

WLKEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +2.5%

Equity Research

Avient Corp (AVNT)

HOLD. 12-month probability-weighted target $44 (+17% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

AVNTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.5%

Equity Research

Alcoa Corp (AA)

HOLD. 12-month probability-weighted target $43 (+3% vs spot). P/E Multiple explains 46% of Monte Carlo outcome variance.

AAEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.1%

Equity Research

Vulcan Materials Company (VMC)

BUY. 12-month probability-weighted target $303 (+24% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

VMCEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +1.2%

Equity Research

Axalta Coating Systems Ltd (AXTA)

HOLD. 12-month probability-weighted target $37 (+12% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

AXTAEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +0.4%

Equity Research

Smurfit WestRock plc (SW)

HOLD. 12-month probability-weighted target $44 (+7% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

SWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.2%

Equity Research

Cabot Corporation (CBT)

HOLD. 12-month probability-weighted target $89 (+19% vs spot). P/E Multiple explains 46% of Monte Carlo outcome variance.

CBTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.8%

Equity Research

PPG Industries Inc (PPG)

HOLD. 12-month probability-weighted target $116 (+12% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

PPGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -2.9%

Equity Research

AngloGold Ashanti (AU)

HOLD. 12-month probability-weighted target $87 (-8% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

AUEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -3.2%

Equity Research

Martin Marietta Materials Inc (MLM)

HOLD. 12-month probability-weighted target $607 (+27% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

MLMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -3.5%

Equity Research

Dow Inc (DOW)

HOLD. 12-month probability-weighted target $29 (+1% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

DOWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -3.9%

Equity Research

International Paper (IP)

HOLD. 12-month probability-weighted target $35 (+9% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

IPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -4.1%

Equity Research

Steel Dynamics Inc (STLD)

HOLD. 12-month probability-weighted target $256 (+7% vs spot). P/E Multiple explains 49% of Monte Carlo outcome variance.

STLDEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -4.9%

Equity Research

Coeur Mining Inc (CDE)

HOLD. 12-month probability-weighted target $17 (-1% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

CDEEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.0%

Equity Research

Linde plc Ordinary Shares (LIN)

HOLD. 12-month probability-weighted target $515 (+7% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

LINEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.3%

Equity Research

Air Products and Chemicals Inc (APD)

HOLD. 12-month probability-weighted target $279 (-1% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

APDEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.3%

Equity Research

Nucor Corp (NUE)

HOLD. 12-month probability-weighted target $252 (+1% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

NUEEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.6%

Equity Research

Graphic Packaging Holding Company (GPK)

HOLD. 12-month probability-weighted target $11 (+29% vs spot). Gross Margin explains 87% of Monte Carlo outcome variance.

GPKEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.6%

Equity Research

Amcor PLC (AMCR)

HOLD. 12-month probability-weighted target $41 (-3% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

AMCREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -7.0%

Equity Research

Crown Holdings Inc (CCK)

HOLD. 12-month probability-weighted target $116 (+7% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

CCKEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -7.2%

Equity Research

RPM International Inc (RPM)

HOLD. 12-month probability-weighted target $100 (+3% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

RPMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.3%

Equity Research

Newmont Corporation (NEM)

HOLD. 12-month probability-weighted target $105 (-11% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

NEMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.9%

Equity Research

Packaging Corp of America (PKG)

HOLD. 12-month probability-weighted target $241 (+4% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

PKGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -13.0%

Equity Research

AptarGroup Inc (ATR)

HOLD. 12-month probability-weighted target $130 (+8% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

ATREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -14.0%

Equity Research

Sherwin-Williams Co (SHW)

HOLD. 12-month probability-weighted target $331 (+4% vs spot). Gross Margin explains 49% of Monte Carlo outcome variance.

SHWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -16.1%

Equity Research

Commercial Metals Company (CMC)

HOLD. 12-month probability-weighted target $65 (+1% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

CMCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -16.6%

Equity Research

Avery Dennison Corp (AVY)

HOLD. 12-month probability-weighted target $159 (-5% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

AVYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -17.0%

Equity Research

Ball Corporation (BALL)

HOLD. 12-month probability-weighted target $59 (+1% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

BALLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -18.4%

Equity Research

Solstice Advanced Materials, Inc (SOLS)

HOLD. 12-month probability-weighted target $57 (-7% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

SOLSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -20.3%

Equity Research

Cleveland-Cliffs Inc (CLF)

SELL. 12-month probability-weighted target $10 (-24% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

CLFEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -20.9%

Equity Research

Ecolab Inc (ECL)

HOLD. 12-month probability-weighted target $273 (-3% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

ECLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -21.2%

Equity Research

Hecla Mining Company (HL)

SELL. 12-month probability-weighted target $14 (-16% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

HLEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -21.3%

Equity Research

Greif Bros Corporation (GEF)

HOLD. 12-month probability-weighted target $72 (-11% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

GEFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -22.4%

Equity Research

NewMarket Corporation (NEU)

SELL. 12-month probability-weighted target $796 (-11% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

NEUEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -25.5%

Equity Research

International Flavors & Fragrances Inc (IFF)

SELL. 12-month probability-weighted target $74 (-12% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

IFFEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -25.5%

Equity Research

LyondellBasell Industries NV (LYB)

HOLD. 12-month probability-weighted target $58 (-4% vs spot). P/E Multiple explains 45% of Monte Carlo outcome variance.

LYBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -25.9%

Equity Research

Freeport-McMoran Copper & Gold Inc (FCX)

SELL. 12-month probability-weighted target $65 (-12% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

FCXEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -27.8%

Equity Research

Ashland Global Holdings Inc (ASH)

SELL. 12-month probability-weighted target $59 (-16% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

ASHEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -32.5%

Equity Research

Reliance Steel & Aluminum Co (RS)

SELL. 12-month probability-weighted target $307 (-24% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

RSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -36.8%

Equity Research

The Mosaic Company (MOS)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

MOSEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

CF Industries Holdings Inc (CF)

Rating suspended since 2026-09-21 — valuation multiple under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

CFEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Corteva Inc (CTVA)

Rating suspended since 2026-10-07 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

CTVAEquity ResearchMonte Carlo

6 October 2026Rating: N/A

Equity Research

Knife River Corporation (KNF)

Rating suspended since 2026-10-10 — quality check pending. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

KNFEquity ResearchMonte Carlo

3 October 2026Rating: N/A

Equity Research

Royal Gold Inc (RGLD)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

RGLDEquity ResearchMonte Carlo

1 October 2026Rating: N/A